Cargando…
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
Novel multitarget-directed ligands BIGI 4a-d and BIGI 5a-d were designed and synthesized with a simple and cost-efficient procedure via a one-pot three-component Biginelli reaction targeting acetyl-/butyrylcholinesterases inhibition, calcium channel antagonism, and antioxidant ability. Among these m...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822022/ https://www.ncbi.nlm.nih.gov/pubmed/36615267 http://dx.doi.org/10.3390/molecules28010071 |
_version_ | 1784865843247579136 |
---|---|
author | Malek, Rim Simakov, Alexey Davis, Audrey Maj, Maciej Bernard, Paul J. Wnorowski, Artur Martin, Helene Marco-Contelles, José Chabchoub, Fakher Dallemagne, Patrick Rochais, Christophe Jozwiak, Krzysztof Ismaili, Lhassane |
author_facet | Malek, Rim Simakov, Alexey Davis, Audrey Maj, Maciej Bernard, Paul J. Wnorowski, Artur Martin, Helene Marco-Contelles, José Chabchoub, Fakher Dallemagne, Patrick Rochais, Christophe Jozwiak, Krzysztof Ismaili, Lhassane |
author_sort | Malek, Rim |
collection | PubMed |
description | Novel multitarget-directed ligands BIGI 4a-d and BIGI 5a-d were designed and synthesized with a simple and cost-efficient procedure via a one-pot three-component Biginelli reaction targeting acetyl-/butyrylcholinesterases inhibition, calcium channel antagonism, and antioxidant ability. Among these multitarget-directed ligands, BIGI 4b, BIGI 4d, and BIGI 5b were identified as promising new hit compounds showing in vitro balanced activities toward the recognized AD targets. In addition, these compounds showed suitable physicochemical properties and a good druglikeness score predicted by Data Warrior software. |
format | Online Article Text |
id | pubmed-9822022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98220222023-01-07 Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation Malek, Rim Simakov, Alexey Davis, Audrey Maj, Maciej Bernard, Paul J. Wnorowski, Artur Martin, Helene Marco-Contelles, José Chabchoub, Fakher Dallemagne, Patrick Rochais, Christophe Jozwiak, Krzysztof Ismaili, Lhassane Molecules Article Novel multitarget-directed ligands BIGI 4a-d and BIGI 5a-d were designed and synthesized with a simple and cost-efficient procedure via a one-pot three-component Biginelli reaction targeting acetyl-/butyrylcholinesterases inhibition, calcium channel antagonism, and antioxidant ability. Among these multitarget-directed ligands, BIGI 4b, BIGI 4d, and BIGI 5b were identified as promising new hit compounds showing in vitro balanced activities toward the recognized AD targets. In addition, these compounds showed suitable physicochemical properties and a good druglikeness score predicted by Data Warrior software. MDPI 2022-12-22 /pmc/articles/PMC9822022/ /pubmed/36615267 http://dx.doi.org/10.3390/molecules28010071 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Malek, Rim Simakov, Alexey Davis, Audrey Maj, Maciej Bernard, Paul J. Wnorowski, Artur Martin, Helene Marco-Contelles, José Chabchoub, Fakher Dallemagne, Patrick Rochais, Christophe Jozwiak, Krzysztof Ismaili, Lhassane Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation |
title | Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation |
title_full | Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation |
title_fullStr | Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation |
title_full_unstemmed | Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation |
title_short | Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation |
title_sort | biginelli reaction synthesis of novel multitarget-directed ligands with ca(2+) channel blocking ability, cholinesterase inhibition, antioxidant capacity, and nrf2 activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822022/ https://www.ncbi.nlm.nih.gov/pubmed/36615267 http://dx.doi.org/10.3390/molecules28010071 |
work_keys_str_mv | AT malekrim biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT simakovalexey biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT davisaudrey biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT majmaciej biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT bernardpaulj biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT wnorowskiartur biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT martinhelene biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT marcocontellesjose biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT chabchoubfakher biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT dallemagnepatrick biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT rochaischristophe biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT jozwiakkrzysztof biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation AT ismaililhassane biginellireactionsynthesisofnovelmultitargetdirectedligandswithca2channelblockingabilitycholinesteraseinhibitionantioxidantcapacityandnrf2activation |